Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

BIRC7 Antikörper (AA 101-200) (Cy5)

BIRC7 Reaktivität: Human, Maus, Ratte WB, IF (p), IF (cc) Wirt: Kaninchen Polyclonal Cy5
Produktnummer ABIN672565
  • Target Alle BIRC7 Antikörper anzeigen
    BIRC7 (Baculoviral IAP Repeat-Containing 7 (BIRC7))
    Bindungsspezifität
    • 14
    • 8
    • 7
    • 6
    • 4
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 101-200
    Reaktivität
    • 56
    • 14
    • 14
    • 2
    • 2
    • 2
    • 1
    Human, Maus, Ratte
    Wirt
    • 48
    • 6
    • 2
    Kaninchen
    Klonalität
    • 49
    • 6
    Polyklonal
    Konjugat
    • 33
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser BIRC7 Antikörper ist konjugiert mit Cy5
    Applikation
    • 49
    • 21
    • 15
    • 12
    • 12
    • 12
    • 10
    • 6
    • 5
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunofluorescence (Cultured Cells) (IF (cc))
    Kreuzreaktivität
    Human, Maus, Ratte
    Homologie
    Dog,Cow
    Aufreinigung
    Purified by Protein A.
    Immunogen
    KLH conjugated synthetic peptide derived from human Livin
    Isotyp
    IgG
    Top Product
    Discover our top product BIRC7 Primärantikörper
  • Applikationshinweise
    IF(IHC-P) 1:50-200
    IF(IHC-F) 1:50-200
    IF(ICC) 1:50-200
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    1 μg/μL
    Buffer
    Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
    Konservierungsmittel
    ProClin
    Vorsichtsmaßnahmen
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
    Haltbarkeit
    12 months
  • Target
    BIRC7 (Baculoviral IAP Repeat-Containing 7 (BIRC7))
    Andere Bezeichnung
    Livin (BIRC7 Produkte)
    Synonyme
    KIAP antikoerper, LIVIN antikoerper, ML-IAP antikoerper, MLIAP antikoerper, RNF50 antikoerper, EIAP/XLX antikoerper, XLX antikoerper, kiap antikoerper, livin antikoerper, ml-iap antikoerper, mliap antikoerper, rnf50 antikoerper, xEIAP antikoerper, RGD1562883 antikoerper, zgc:165605 antikoerper, E130019N06 antikoerper, Livin antikoerper, birc7 antikoerper, bird7a antikoerper, xEIAP/XLX antikoerper, xlx antikoerper, EIAP/XLX-B antikoerper, birc7b antikoerper, baculoviral IAP repeat containing 7 antikoerper, baculoviral IAP repeat-containing 7 antikoerper, baculoviral IAP repeat-containing 7 (livin) antikoerper, baculoviral IAP repeat containing 7 S homeolog antikoerper, baculoviral IAP repeat containing 7 L homeolog antikoerper, BIRC7 antikoerper, birc7 antikoerper, Birc7 antikoerper, birc7.S antikoerper, birc7.L antikoerper
    Hintergrund

    Synonyms: KIAP, LIVIN, MLIAP, RNF50, ML-IAP, Baculoviral IAP repeat-containing protein 7, Kidney inhibitor of apoptosis protein, Melanoma inhibitor of apoptosis protein, RING finger protein 50, BIRC7, UNQ5800/PRO19607/PRO21344

    Background: Apoptotic regulator capable of exerting proapoptotic and anti-apoptotic activities and plays crucial roles in apoptosis, cell proliferation, and cell cycle control. Its anti-apoptotic activity is mediated through the inhibition of CASP3, CASP7 and CASP9, as well as by its E3 ubiquitin-protein ligase activity. As it is a weak caspase inhibitor, its anti-apoptotic activity is thought to be due to its ability to ubiquitinate DIABLO/SMAC targeting it for degradation thereby promoting cell survival. May contribute to caspase inhibition, by blocking the ability of DIABLO/SMAC to disrupt XIAP/BIRC4-caspase interactions. Protects against apoptosis induced by TNF or by chemical agents such as adriamycin, etoposide or staurosporine. Suppression of apoptosis is mediated by activation of MAPK8/JNK1, and possibly also of MAPK9/JNK2. This activation depends on TAB1 and NR2C2/TAK1. In vitro, inhibits CASP3 and proteolytic activation of pro-CASP9. Isoform 1 blocks staurosporine-induced apoptosis. Isoform 2 blocks etoposide-induced apoptosis. Isoform 2 protects against natural killer (NK) cell killing whereas isoform 1 augments killing.

    Gen-ID
    79444
    UniProt
    Q96CA5
Sie sind hier:
Kundenservice